Latest Breaking News On - Source qapel medical inc - Page 1 : comparemela.com

Q Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens Joins Board of Directors Investment Will Be Used to Scale Product Platform, Expand Nationally, Internationally and Grow Team News provided by Share this article Share this article FREMONT, Calif., Feb. 11, 2021 /PRNewswire/ Q Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included River Cities Capital, Soleus Capital, and incumbent investor Research Corporation Technologies (RCT). Scott Huennekens, former Chairman, CEO and President of Verb Surgical, and Carter McNabb, Managing Director, River Cities Capital, will join the Board of Directors.

Scott huennekensCarter mcnabbKing nelsonPrnewswire qapel medical incSource qapel medical incResearch corporation technologiesApel medicalRiver cities capitalSoleus capitalVerb surgicalManaging directorQ apel medicalWalrus balloon guide catheterWahoo controlQ 39 apel medicalகார்ட்டர் மக்ந்யாப்ப்